AAAAAA

   
Results: 1-16 |
Results: 16
DIFFERENTIAL RESPONSES TO CHEMOIMMUNOTHERAPY IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
Authors: MAINWARING PN ATKINSON H CHANG J MOORE J HANCOCK BW GUILLOU PJ OSKAM R GORE ME
Citation: Pn. Mainwaring et al., DIFFERENTIAL RESPONSES TO CHEMOIMMUNOTHERAPY IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA, European journal of cancer, 33(9), 1997, pp. 1388-1392
PROLONGED CONTINUOUS HEPATIC-ARTERY INFUSION WITH INTERLEUKIN-2 IN UNRESECTABLE LIVER METASTASES OF COLORECTAL-CANCER - A PHASE IA-B STUDY
Authors: GOEY SH EGGERMONT AMM OSKAM R WIGGERS T BOLHUIS RLH STOTER G
Citation: Sh. Goey et al., PROLONGED CONTINUOUS HEPATIC-ARTERY INFUSION WITH INTERLEUKIN-2 IN UNRESECTABLE LIVER METASTASES OF COLORECTAL-CANCER - A PHASE IA-B STUDY, Annals of oncology, 7(3), 1996, pp. 317-319
PILOT-STUDY OF IMMUNOTHERAPY USING INTERLEUKIN-2 IN CHILDREN WITH SOLID TUMORS OR LYMPHOMAS
Authors: BOUFFET E MICHON J FRAPPAZ D NEGRIER S COMBARET V DELATTRE O COCHAT P FLORET D DOZ F STAMM D CLAPISSON G OSKAM R LASSET C PACQUEMENT H ZUCKER JM BRUNATMENTIGNY M FAVROT M PHILIP T
Citation: E. Bouffet et al., PILOT-STUDY OF IMMUNOTHERAPY USING INTERLEUKIN-2 IN CHILDREN WITH SOLID TUMORS OR LYMPHOMAS, International journal of pediatric hematology/oncology, 2(6), 1995, pp. 489-493
INTENSIVE REGIMEN OF CYTOKINES WITH INTERLEUKIN-2 AND INTERFERON ALFA-2B IN SELECTED PATIENTS WITH METASTATIC RENAL-CARCINOMA
Authors: NEGRIER S MERCATELLO A BRET M MERROUCHE Y CORONEL B FAVROT M GASPARD M DOREZ D PHILIP I LANIER F THIESSE P OSKAM R PALMER P TABAH I MOSKOVTCHENKO JF PHILIP T
Citation: S. Negrier et al., INTENSIVE REGIMEN OF CYTOKINES WITH INTERLEUKIN-2 AND INTERFERON ALFA-2B IN SELECTED PATIENTS WITH METASTATIC RENAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 17(1), 1995, pp. 62-68
A PHASE-III STUDY OF RECOMBINANT INTERLEUKIN-2, 5-FLUOROURACIL AND LEUCOVORIN VERSUS 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH UNRESECTABLE OR METASTATIC COLORECTAL-CARCINOMA
Authors: HEYS SD EREMIN O RUGGERI EM PEIN F RAINER H OSKAM R DEPEUTER RA PALMER PA FRANKS CR
Citation: Sd. Heys et al., A PHASE-III STUDY OF RECOMBINANT INTERLEUKIN-2, 5-FLUOROURACIL AND LEUCOVORIN VERSUS 5-FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH UNRESECTABLE OR METASTATIC COLORECTAL-CARCINOMA, European journal of cancer, 31A(1), 1995, pp. 19-25
A MULTICENTER PHASE-II CLINICAL-TRIAL USING DACARBAZINE AND CONTINUOUS-INFUSION INTERLEUKIN-2 FOR METASTATIC MELANOMA - CLINICAL-DATA AND IMMUNOMONITORING
Authors: DUMMER R GORE ME HANCOCK BW GUILLOU PJ GROBBEN HC BECKER JC OSKAM R DIELEMAN JP BURG G
Citation: R. Dummer et al., A MULTICENTER PHASE-II CLINICAL-TRIAL USING DACARBAZINE AND CONTINUOUS-INFUSION INTERLEUKIN-2 FOR METASTATIC MELANOMA - CLINICAL-DATA AND IMMUNOMONITORING, Cancer, 75(4), 1995, pp. 1038-1044
FEASIBILITY AND TOLERANCE OF 2 ROUTES OF PREOPERATIVE INTERLEUKINE 2 ADMINISTRATION
Authors: HOUVENAEGHEL G BLACHE JL ARNAUD S BLADOU F BRUN JP CHAUDET H OSKAM R DELPERO JR GUERINEL G
Citation: G. Houvenaeghel et al., FEASIBILITY AND TOLERANCE OF 2 ROUTES OF PREOPERATIVE INTERLEUKINE 2 ADMINISTRATION, Bulletin du cancer, 82(12), 1995, pp. 1052-1059
DIFFERENT PREOPERATIVE INTERLEUKIN-2 ADMINISTRATIONS IN ADVANCED CANCER-PATIENTS
Authors: HOUVENAEGHEL G BLACHE JL OLIVE D DELPERO JR BLADOU F ARNAUD S OSKAM R GUERINEL G
Citation: G. Houvenaeghel et al., DIFFERENT PREOPERATIVE INTERLEUKIN-2 ADMINISTRATIONS IN ADVANCED CANCER-PATIENTS, British Journal of Surgery, 82, 1995, pp. 111-111
INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 IN PLEURAL MESOTHELIOMA - A PHASE I-II STUDY
Authors: GOEY SH EGGERMONT AMM PUNT CJA SLINGERLAND R GRATAMA JW OOSTEROM R OSKAM R BOLHUIS RLH STOTER G
Citation: Sh. Goey et al., INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 IN PLEURAL MESOTHELIOMA - A PHASE I-II STUDY, British Journal of Cancer, 72(5), 1995, pp. 1283-1288
PHASE-I STUDY OF RHU MCSF BY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED MALIGNANCY
Authors: STOPPA AM VIENS P BLAISE D OLIVE D OSKAM R GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., PHASE-I STUDY OF RHU MCSF BY CONTINUOUS-INFUSION IN PATIENTS WITH ADVANCED MALIGNANCY, Experimental hematology, 22(8), 1994, pp. 703-703
HUMAN RESIDENT PERITONEAL-MACROPHAGES - PHENOTYPE AND BIOLOGY
Authors: EISCHEN A DUCLOS B SCHMITTGOGUEL M ROUYER N BERGERAT JP HUMMEL M OSKAM R OBERLING F
Citation: A. Eischen et al., HUMAN RESIDENT PERITONEAL-MACROPHAGES - PHENOTYPE AND BIOLOGY, British Journal of Haematology, 88(4), 1994, pp. 712-722
SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: RAVAUD A NEGRIER S CANY L MERROUCHE Y LEGUILLOU M BLAY JY CLAVEL M GASTON R OSKAM R PHILIP T
Citation: A. Ravaud et al., SUBCUTANEOUS LOW-DOSE RECOMBINANT INTERLEUKIN-2 AND ALPHA-INTERFERON IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, British Journal of Cancer, 69(6), 1994, pp. 1111-1114
A COMPARISON OF 2 MODES OF ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 - CONTINUOUS INTRAVENOUS-INFUSION ALONE VERSUS SUBCUTANEOUS ADMINISTRATION PLUS INTERFERON-ALPHA IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA
Authors: PALMER PA ATZPODIEN J PHILIP T NEGRIER S KIRCHNER H VONDERMAASE H GEERTSEN P EVERS P LORIAUX E OSKAM R ROEST G VINKE J FRANKS CR
Citation: Pa. Palmer et al., A COMPARISON OF 2 MODES OF ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 - CONTINUOUS INTRAVENOUS-INFUSION ALONE VERSUS SUBCUTANEOUS ADMINISTRATION PLUS INTERFERON-ALPHA IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA, Cancer biotherapy, 8(2), 1993, pp. 123-136
TRANSFORMATION OF MOUSE FIBROBLASTS WITH THE ONCOGENES H-RAS OR TRK IS ASSOCIATED WITH PRONOUNCED CHANGES IN DRUG SENSITIVITY AND METABOLISM
Authors: PETERS GJ WETS M KEEPERS YPAM OSKAM R VANARKOTTE J NOORDHUIS P SMID K PINEDO HM
Citation: Gj. Peters et al., TRANSFORMATION OF MOUSE FIBROBLASTS WITH THE ONCOGENES H-RAS OR TRK IS ASSOCIATED WITH PRONOUNCED CHANGES IN DRUG SENSITIVITY AND METABOLISM, International journal of cancer, 54(3), 1993, pp. 450-455
A PHASE-III STUDY OF RECOMBINANT INTERLEUKIN-2 AND 5-FLUOROURACIL CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: HAMBLIN TJ SADULLAH S WILLIAMSON P STEVENSON J OSKAM R PALMER P FRANKS CR
Citation: Tj. Hamblin et al., A PHASE-III STUDY OF RECOMBINANT INTERLEUKIN-2 AND 5-FLUOROURACIL CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, British Journal of Cancer, 68(6), 1993, pp. 1186-1189
PATIENTS WITH METASTATIC RENAL-CARCINOMA CANDIDATE FOR IMMUNOTHERAPY WITH CYTOKINES - ANALYSIS OF A SINGLE INSTITUTION STUDY ON 181 PATIENTS
Authors: PHILIP T NEGRIER S LASSET C CORONEL B BRET M BLAY JY MERROUCHE Y CARRIE C KAEMMERLEN P CHAUVIN F FAVROT M OSKAM R TABAH I CLAVEL M MOSKOVTCHENKO JF MERCATELLO A
Citation: T. Philip et al., PATIENTS WITH METASTATIC RENAL-CARCINOMA CANDIDATE FOR IMMUNOTHERAPY WITH CYTOKINES - ANALYSIS OF A SINGLE INSTITUTION STUDY ON 181 PATIENTS, British Journal of Cancer, 68(5), 1993, pp. 1036-1042
Risultati: 1-16 |